Table 1 Baseline Characteristics and Intra-Operative Medication Utilization
Placebo penile block (n = 60) | Bupivacaine penile block (n = 56) | p-value | |
|---|---|---|---|
Baseline clinical characteristics | |||
Age (range) | 60.8 (47-72) | 61.2 (46-75) | 0.78 |
BMI (range) | 27.8 (18.8-40.0) | 27.1 (20.1-38.5) | 0.28 |
Diabetes (%) | 4 (6.4%) | 6 (10.3%) | 0.74 |
PVD (%) | 1 (1.6%) | 1 (1.7%) | 0.96 |
History of narcotics use (%) | 0 (0%) | 1 (3.1%) | 0.48 |
PSA (range, ng/mL) | 6.2 (0.9-24.0) | 6.6 (0.9-25.7) | 0.54 |
Operative time (mean ± SD, minutes) | 186 ± 79 | 166 ± 80 | 0.18 |
Preoperative Gleason score | 0.84 | ||
6 | 19 (32%) | 22 (39%) | |
7 | 34 (58%) | 28 (49%) | |
≥8 | 6 (10%) | 7 (12%) | |
Intra-operative medications | |||
Opiates (mean ± SD, mg MED) | 94.1 ± 39.6 | 89.3 ± 38.2 | 0.51 |
Ketorolac usage | 38% | 34% | 0.63 |